Presentation, treatment, and outcomes of dural metastases in men with metastatic castrate-resistant prostate cancer: A case series

Journal of Palliative Medicine

Volumn 13, Issue 9, 2010, Pages 1125-1129

  Lawton, Andrew ^a   Sudakoff, Gary ^a   Dezelan, Lisa C ^a   Davis, Nancy ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; DOCETAXEL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CRANIAL NEUROPATHY; DURAL METASTASIS; GLEASON SCORE; HUMAN; MALE; METASTASIS; METASTATIC CASTRATE RESISTANT PROSTATE CANCER; PROSTATE CANCER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AUTOPSY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77956578867     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0416     Document Type: Article

References (31)

1. American Cancer Society: Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society, 2010.
2. McLeod DG, Crawford ED, DeAntoni EP: Combined an-drogen blockade: the gold standard for metastatic prostate cancer. Eur Urol 1997;32(Suppl 3):70-77.
3. Petrylak DP, Tangen CM, Hussain MH: Docetaxel and es-tramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004;15: 1513-1520.
4. Tannock IF, de Wit R, Berry WR: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;15:1502-1512.
5. Penley MW, Kim YC, Pribram HF: Subdural metastases from prostatic adenocarcinoma. Surg Neurol 1981;16:131-134.
6. Allen RS, Sarma PR: Pseudopseudotumor cerebri: Me-ningeal carcinomatosis presenting as benign intracranial hypertension. South Med J 1987;80:1182-1183.
7. Bentley AM, Keen JC: Dural metastases in prostate cancer. Clin Oncol (R Coll Radiol) 2003;15:165-166.
8. Bucci MN, Farhat SM: Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma. J Urol 1986;135: 803-804.
9. Capito PR, Wang H, Brem H, Ahn HS, Bryan RN: Magnetic resonance imaging diagnosis of an intracranial metastasis of adenocarcinoma of the prostate: case report. Md Med J 1991;40:113-115.
10. Castaldo JE, Bernat JL, Meier FA, Schned AR: Intracranial metastases due to prostatic carcinoma. Cancer 1983;52:1739-1747.
11. Confavreux CB, Cotton F, Tebib JG: Advanced MRI could help to differentiate meningeal carcinomatosis with mass effect from cerebral metastasis in prostate cancer. Bull Cancer 2006;93:E31-E35.
12. Delaney P: Subdural metasases from prostatic adenocarci-noma. J Neurol Neurosurg Psychiatry 1983;46:186.
13. Fink LH: Metastasis of prostatic adenocarcinoma simulating a falx meningioma. Surg Neurol 1979;12:253-258.
14. Neelapu S, Figg WD, Dahut W, Reed E: Leptomeningeal carcinomatosis in metastatic prostate cancer. South Med J 2002;95:107-108.
15. Olson KB, Pienta KJ: Prostate cancer presenting as visual changes. Anticancer Res 2006;26:755-758.
16. Scarrow AM, Rajendran PR, Marion D: Metastatic prostate adenocarcinoma of the dura mater. Br J Neurosurg 2000;14; 473-474.
17. Tagle P, Villanueva P, Torrealba G, Huete I: Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol 2002;58:241-245.
18. Tomlin JM, Alleyne CH: Transdural metastasis from ade-nocarcinoma of the prostate mimicking subdural hematoma: case report. Surg Neurol 2002;58:329-331.
19. Demierre B, Berney J. [Intracranial metastases of cancer of the prostate]. Neurochirurgie 1983;29:143-149.
20. Kleinschmidt-DeMasters BK: Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 2001;125:880-887.
21. Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyr-itsis AP, Puduvalli VK: Brain metastasis from prostate carcinoma: The M.D. Anderson Cancer Center Experience. Cancer 2003;98:363-368.
22. Saitoh H, Hida M, Shimbo T, Nakamura K, Yamagata J, Satoh T: Metastatic patterns of prostate cancer. Correlation between sites and number of organs involved. Cancer 1984;54:3078-3084.
23. Bubendorf L, Schopfer A, Wanger U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ: Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol 2000;31:578-583.
24. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumor: Experience of 90 patients. Cancer 1982;49:759-772.
25. Batson OV: The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 1995;312:4-9.
26. Lewis I: Cerebellar metastases from prostatic carcinoma. A case report. Neurology 1967;17:698-702.
27. Sutton MA, Watkins HL, Green LK, Kadmon D: Intracranial metastases as the first manifestation of prostate cancer. Urology 1996;48:789-793.
28. Rao KG: Carcinoma of prostate presenting as intracranial tumor with multiple cranial nerve palsies. Urology 1982; 19:433-435.
29. Posner J: Intracranial metastasis. In: Posner J (eds): Neurologic Complications of Cancer. Philadelphia: F.A. Davis, 1995, pp. 77-110.
30. Nayak L, Abrey LE, Iwamoto FM: Intracranial dural me-tastases. Cancer 2009;115:1947-1953.
31. Lin NU, Winer EP: Brain metastases: The HER2 paradigm. Clin Cancer Res 2007;13:1648-1655.